- Home
- STRS vs IVVD Comparison
STRS vs IVVD Comparison
Compare STRS & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRS
- IVVD
- Stock Information
- Founded
- STRS 1992
- IVVD 2020
- Country
- STRS United States
- IVVD United States
- Employees
- STRS N/A
- IVVD N/A
- Industry
- STRS Homebuilding
- IVVD Biotechnology: Pharmaceutical Preparations
- Sector
- STRS Real Estate
- IVVD Health Care
- Exchange
- STRS Nasdaq
- IVVD Nasdaq
- Market Cap
- STRS 133.9M
- IVVD 123.8M
- IPO Year
- STRS N/A
- IVVD 2021
- Fundamental
- Price
- STRS $19.39
- IVVD $0.65
- Analyst Decision
- STRS
- IVVD Strong Buy
- Analyst Count
- STRS 0
- IVVD 3
- Target Price
- STRS N/A
- IVVD $7.52
- AVG Volume (30 Days)
- STRS 6.7K
- IVVD 1.8M
- Earning Date
- STRS 05-13-2025
- IVVD 05-15-2025
- Dividend Yield
- STRS N/A
- IVVD N/A
- EPS Growth
- STRS N/A
- IVVD N/A
- EPS
- STRS 0.24
- IVVD N/A
- Revenue
- STRS $54,183,000.00
- IVVD $25,384,000.00
- Revenue This Year
- STRS N/A
- IVVD $606.63
- Revenue Next Year
- STRS N/A
- IVVD $83.30
- P/E Ratio
- STRS $84.17
- IVVD N/A
- Revenue Growth
- STRS 213.74
- IVVD N/A
- 52 Week Low
- STRS $15.41
- IVVD $0.36
- 52 Week High
- STRS $30.66
- IVVD $2.74
- Technical
- Relative Strength Index (RSI)
- STRS 59.23
- IVVD 52.71
- Support Level
- STRS $15.10
- IVVD $0.52
- Resistance Level
- STRS $20.50
- IVVD $0.80
- Average True Range (ATR)
- STRS 0.84
- IVVD 0.08
- MACD
- STRS 0.40
- IVVD 0.01
- Stochastic Oscillator
- STRS 79.44
- IVVD 50.70
About STRS Stratus Properties Inc.
Stratus Properties Inc is a diversified real estate company operating in the United States. It is engaged in the acquisition, entitlement, development, management, operation and sale of commercial, multi- and single-family residential real estate properties, located in the Austin Texas area and other select markets in Texas. It operates its business through two segments namely, Real Estate Operations and Leasing Operations. Real Estate Operations segment encompasses activities associated with entitlement, development, and sale of real estate. Leasing Operations segment involves leasing of commercial space at retail and mixed-use properties and residences in multi-family properties that company developed. Majority of revenue is from Real Estate Operations.
About IVVD Invivyd Inc.
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.